Open Access Maced J Med Sci
December 2019
Background: In recent times, scientists have found new treatments for colorectal cancer patients.
Aim: The study is to evaluate the efficacy and toxicity of triplet combination chemotherapy of 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) for patients with metastatic colorectal cancer in stage IV.
Methods: Uncontrolled clinical trial carried on 39 stage IV colorectal cancer patients.